Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
J Immunother Cancer ; 12(3)2024 Mar 13.
Article in English | MEDLINE | ID: mdl-38485187

ABSTRACT

BACKGROUND: Sperm acrosomal SLLP1 binding (SAS1B) protein is found in oocytes, which is necessary for sperm-oocyte interaction, and also in uterine and pancreatic cancers. Anti-SAS1B antibody-drug conjugates (ADCs) arrested growth in these cancers. However, SAS1B expression in cancers and normal tissues has not been characterized. We hypothesized that SAS1B is expressed on the surface of other common solid cancer cells, but not on normal tissue cells, and might be selectively targeted therapeutically. METHODS: SAS1B expression in human normal and cancer tissues was determined by immunohistochemistry, and complementary DNA (cDNA) libraries were employed to PCR amplify human SAS1B and its transcripts. Monoclonal antibodies (mAbs) to human SAS1B were generated using mouse hybridomas. SAS1B deletion constructs were developed to map SAS1B's epitope, enabling the creation of a blocking peptide. Indirect immunofluorescence (IIF) of human transfected normal and cancer cells was performed to assess SAS1B expression. SAS1B intracellular versus surface expression in normal and tumor tissues was evaluated by flow cytometry after staining with anti-SAS1B mAb, with specificity confirmed with the blocking peptide. Human cancer lines were treated with increasing mAb and ADC concentrations. ATP was quantitated as a measure of cell viability. RESULTS: SAS1B expression was identified in a subset of human cancers and the cytoplasm of pancreatic islet cells. Two new SAS1B splice variants were deduced. Monoclonal antibodies were generated to SAS1B splice variant A. The epitope for mAbs SB2 and SB5 is between SAS1B amino acids 32-39. IIF demonstrated intracellular SAS1B expression in transfected kidney cells and on the cell surface of squamous cell lung carcinoma. Flow cytometry demonstrated intracellular SAS1B expression in all tumors and some normal cells. However, surface expression of SAS1B was identified only on cancer cells. SB2 ADC mediated dose-dependent cytotoxic killing of multiple human cancer lines. CONCLUSION: SAS1B is a novel cancer-oocyte antigen with cell surface expression restricted to cancer cells. In vitro, it is an effective target for antibody-mediated cancer cell lysis. These findings support further exploration of SAS1B as a potential therapeutic cancer target in multiple human cancers, either with ADC or as a chimeric antigen receptor-T (CAR-T) cell target.


Subject(s)
Immunoconjugates , Neoplasms , Male , Humans , Mice , Animals , Immunoconjugates/pharmacology , Immunoconjugates/therapeutic use , Semen , Oocytes/metabolism , Neoplasms/drug therapy , Neoplasms/genetics , Neoplasms/metabolism , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal/therapeutic use , Epitopes , Peptides/metabolism
2.
Oncotarget ; 9(10): 8972-8984, 2018 Feb 06.
Article in English | MEDLINE | ID: mdl-29507667

ABSTRACT

Successful therapeutic options remain elusive for pancreatic cancer. The exquisite sensitivity and specificity of humoral and cellular immunity may provide therapeutic approaches if antigens specific for pancreatic cancer cells can be identified. Here we characterize SAS1B (ovastacin, ASTL, astacin-like), a cancer-oocyte antigen, as an attractive immunotoxin target expressed at the surface of human pancreatic cancer cells, with limited expression among normal tissues. Immunohistochemistry shows that most pancreatic cancers are SAS1Bpos (68%), while normal pancreatic ductal epithelium is SAS1Bneg. Pancreatic cancer cell lines developed from patient-derived xenograft models display SAS1B cell surface localization, in addition to cytoplasmic expression, suggesting utility for SAS1B in multiple immunotherapeutic approaches. When pancreatic cancer cells were treated with an anti-SAS1B antibody-drug conjugate, significant cell death was observed at 0.01-0.1 µg/mL, while SAS1Bneg human keratinocytes were resistant. Cytotoxicity was correlated with SAS1B cell surface expression; substantial killing was observed for tumors with low steady state SAS1B expression, suggesting a substantial proportion of SAS1Bpos tumors can be targeted in this manner. These results demonstrate SAS1B is a surface target in pancreatic cancer cells capable of binding monoclonal antibodies, internalization, and delivering cytotoxic drug payloads, supporting further development of SAS1B as a novel target for pancreatic cancer.

3.
ChemMedChem ; 12(22): 1857-1865, 2017 11 22.
Article in English | MEDLINE | ID: mdl-28952188

ABSTRACT

Testis-specific serine/threonine kinase 2 (TSSK2) is an important target for reversible male contraception. A high-throughput screen of ≈17 000 compounds using a mobility shift assay identified two potent series of inhibitors having a pyrrolopyrimidine or pyrimidine core. The pyrrolopyrimidine 10 (IC50 22 nm; GSK2163632A) and the pyrimidine 17 (IC50 31 nm; ALK inhibitor 1) are the most potent TSSK2 inhibitors in these series, which contain the first sub-100 nanomolar inhibitors of any TSSK isoform reported, except for the broad kinase inhibitor staurosporine. The novel, potent pyrimidine TSSK2 inhibitor compound 19 (IC50 66 nm; 2-[[5-chloro-2-[2-methoxy-4-(1-methylpiperidin-4-yl)anilino]pyrimidin-4-yl]amino]-N-methylbenzenesulfonamide) lacks the potential for metabolic activation. Compound 19 had a potency rank order of TSSK1>TSSK2>TSSK3>TSSK6, indicating that potent dual inhibitors of TSSK1/2 can be identified, which may be required for a complete contraceptive effect. The future availability of a TSSK2 crystal structure will facilitate structure-based discovery of selective TSSK inhibitors from these pyrrolopyrimidine and pyrimidine scaffolds.


Subject(s)
Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyrimidines/pharmacology , Pyrroles/pharmacology , Dose-Response Relationship, Drug , High-Throughput Screening Assays , Humans , Molecular Structure , Protein Kinase Inhibitors/chemical synthesis , Protein Kinase Inhibitors/chemistry , Protein Serine-Threonine Kinases/isolation & purification , Protein Serine-Threonine Kinases/metabolism , Pyrimidines/chemical synthesis , Pyrimidines/chemistry , Pyrroles/chemical synthesis , Pyrroles/chemistry , Structure-Activity Relationship
5.
Protein Expr Purif ; 121: 88-96, 2016 May.
Article in English | MEDLINE | ID: mdl-26777341

ABSTRACT

The testis-specific serine/threonine kinase 2 (TSSK2) has been proposed as a candidate male contraceptive target. Development of a selective inhibitor for this kinase first necessitates the production of highly purified, soluble human TSSK2 and its substrate, TSKS, with high yields and retention of biological activity for crystallography and compound screening. Strategies to produce full-length, soluble, biologically active hTSSK2 in baculovirus expression systems were tested and refined. Soluble preparations of TSSK2 were purified by immobilized-metal affinity chromatography (IMAC) followed by gel filtration chromatography. The biological activities of rec.hTSSK2 were verified by in vitro kinase and mobility shift assays using bacterially produced hTSKS (isoform 2), casein, glycogen synthase peptide (GS peptide) and various TSKS peptides as target substrates. Purified recombinant hTSSK2 showed robust kinase activity in the in vitro kinase assay by phosphorylating hTSKS isoform 2 and casein. The ATP Km values were similar for highly and partially purified fractions of hTSSK2 (2.2 and 2.7 µM, respectively). The broad spectrum kinase inhibitor staurosporine was a potent inhibitor of rec.hTSSK2 (IC50 = 20 nM). In vitro phosphorylation experiments carried out with TSKS (isoform 1) fragments revealed particularly strong phosphorylation of a recombinant N-terminal region representing aa 1-150 of TSKS, indicating that the N-terminus of human TSKS is phosphorylated by human TSSK2. Production of full-length enzymatically active recombinant TSSK2 kinase represents the achievement of a key benchmark for future discovery of TSSK inhibitors as male contraceptive agents.


Subject(s)
Contraceptive Agents, Male/pharmacology , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/metabolism , Recombinant Proteins/biosynthesis , Baculoviridae/genetics , Caseins/metabolism , Cytoskeletal Proteins , Enzyme Inhibitors/pharmacology , Gene Expression/drug effects , Humans , Male , Phosphoproteins , Phosphorylation/drug effects , Protein Domains , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Recombinant Proteins/genetics , Staurosporine/pharmacology
6.
Oncotarget ; 6(30): 30194-211, 2015 Oct 06.
Article in English | MEDLINE | ID: mdl-26327203

ABSTRACT

The metalloproteinase SAS1B [ovastacin, ASTL, astacin-like] was immunolocalized on the oolemma of ovulated human oocytes and in normal ovaries within the pool of growing oocytes where SAS1B protein was restricted to follicular stages spanning the primary-secondary follicle transition through ovulation. Gene-specific PCR and immunohistochemical studies revealed ASTL messages and SAS1B protein in both endometrioid [74%] and malignant mixed Mullerian tumors (MMMT) [87%] of the uterus. A MMMT-derived cell line, SNU539, expressed cell surface SAS1B that, after binding polyclonal antibodies, internalized into EEA1/LAMP1-positive early and late endosomes. Treatment of SNU539 cells with anti-SAS1B polyclonal antibodies caused growth arrest in the presence of active complement. A saporin-immunotoxin directed to SAS1B induced growth arrest and cell death. The oocyte restricted expression pattern of SAS1B among adult organs, cell-surface accessibility, internalization into the endocytic pathway, and tumor cell growth arrest induced by antibody-toxin conjugates suggest therapeutic approaches that would selectively target tumors while limiting adverse drug effects in healthy cells. The SAS1B metalloproteinase is proposed as a prototype cancer-oocyte tumor surface neoantigen for development of targeted immunotherapeutics with limited on-target/off tumor effects predicted to be restricted to the population of growing oocytes.


Subject(s)
Antibodies/pharmacology , Antigens, Neoplasm , Immunoconjugates/pharmacology , Immunotherapy/methods , Metalloproteases/antagonists & inhibitors , Mixed Tumor, Mullerian/drug therapy , Ribosome Inactivating Proteins, Type 1/pharmacology , Uterine Neoplasms/drug therapy , Amino Acid Sequence , Antibodies/metabolism , Antibodies/toxicity , Antigens, Neoplasm/genetics , Antigens, Neoplasm/immunology , Antigens, Neoplasm/metabolism , Cell Death/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Endocytosis , Female , Humans , Immunoconjugates/metabolism , Immunoconjugates/toxicity , Immunotherapy/adverse effects , Metalloproteases/genetics , Metalloproteases/immunology , Metalloproteases/metabolism , Mixed Tumor, Mullerian/enzymology , Mixed Tumor, Mullerian/genetics , Mixed Tumor, Mullerian/immunology , Mixed Tumor, Mullerian/pathology , Molecular Sequence Data , Molecular Targeted Therapy , Oocytes/drug effects , Oocytes/enzymology , Ribosome Inactivating Proteins, Type 1/metabolism , Ribosome Inactivating Proteins, Type 1/toxicity , Saporins , Signal Transduction/drug effects , Time Factors , Uterine Neoplasms/enzymology , Uterine Neoplasms/genetics , Uterine Neoplasms/immunology , Uterine Neoplasms/pathology
7.
Biol Reprod ; 92(5): 129, 2015 May.
Article in English | MEDLINE | ID: mdl-25761597

ABSTRACT

ESP1/SPESP1 is a testis-specific, postmeiotic gene expressed in round spermatids that encodes equatorial segment protein 1, an intra-acrosomal protein found in the acrosomal matrix and on the luminal surface of the inner and outer acrosomal membranes within the equatorial segment domain of mature spermatozoa. A comparison of testicular protein extracts with caput, corpus, and caudal epididymal sperm proteins revealed striking differences in the apparent masses of SPESP1 isoforms. The predominant isoforms of SPESP1 in the testis were 77 and 67 kDa, with 47-kDa forms present to a minor degree. In contrast, SPESP1 isoforms of 47 and 43 kDa were found in caput, corpus, and caudal sperm, indicating that SPESP1 undergoes noticeable mass changes during spermiogenesis and/or subsequent transport to the epididymis. On two-dimensional (2D) SDS-PAGE, testicular SPESP1 isoforms resolved as a train of pI values from 4.9 to 5.2. Immunoprecipitated 77-kDa SPESP1 from testis reacted with the glycoprofile stain after one-dimensional and 2D gel electrophoresis, indicating that the 77-kDa testicular isoform was highly glycosylated. One charge variant of the 67-kDa isoform was also glycoprofile positive after 2D gel resolution. The 47- and 43-kDa isoforms of SPESP1 from epididymal sperm did not stain with glycoprofile, suggesting an absence of, or few, glycoprofile-sensitive glycoconjugates in epididymal SPESP1. Treatment of testicular extracts with a variety of glycosidases resulted in mass shifts in immunoreactive SPESP1, indicating that testicular SPESP1 was glycosylated and that terminal sialic acid, N- and O-glycans were present. A mixture of deglycosidase enzymes (including PNGase-F, neuraminidase, beta1-4 galactosidase, endo-alpha-N-acetylgalactosaminidase, and beta N-acetyl-glucosaminidase) completely eliminated the 77- and 67-kDa SPESP1 bands and resulted in the appearance of 75-, 60-, 55-, 50-, 47-, and 43-kDa forms, confirming that both the 77- and 67-kDa testicular forms of SPESP1 contain complex carbohydrate residues. Treatment of caudal epididymal sperm with PNGase-F enzymes showed a faint deglycosylated band at 30 kDa, but neuraminidase did not result in any molecular shift, indicating that epididymal sperm SPESP1 did not contain sialic acid/N-acetylglucosamine residues. These findings are consistent with the hypothesis that SPSPESP1 undergoes significant glycosylation in the testis and that the majority of these glycoconjugates are removed by the time sperm reach the caput epididymis. Studies of the fate of SPESP1 after the acrosome reaction localized SPESP1 to the equatorial segment region in both noncapacitated and capacitated, acrosome-reacted sperm. During capacitation, SPESP1 underwent proteolysis, resulting in a 27-kDa fragment. Zona-free oocytes incubated with recSPESP1 protein showed complementary binding sites on the microvillar oolemmal domain. Both recSPESP1 and anti-recSPESP1 antibody inhibited in vitro fertilization.


Subject(s)
Carrier Proteins/metabolism , Gene Expression Regulation/physiology , Seminal Plasma Proteins/metabolism , Spermatogenesis/physiology , Animals , Antibodies , Carrier Proteins/genetics , Cloning, Molecular , Epididymis/physiology , Glycosylation , Male , Mice , Protein Isoforms , Seminal Plasma Proteins/genetics , Testis/physiology
8.
Environ Entomol ; 43(3): 642-53, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24690599

ABSTRACT

When laboratory host specificity tests on weed biological control agents produce ambiguous results or are suspected of producing false-positive findings, field cage or open field tests can be used to help determine the true ecological host range of the agent. The leaf beetle Diorhabda elongata (Brullé) from Crete, imported to the United States for the control of saltcedar (Tamarix spp., Tamaricaceae), showed a low but variable ovipositional response to nontarget Frankenia spp. (Frankeniaceae) in previous laboratory tests conducted in small cages, where up to 11.4% of eggs were laid on these native plants. Results from field tests presented in this article show that no eggs were laid on Frankenia palmeri S. Watson and significantly more eggs were always laid on Tamarix ramosissima Ledebour than Frankenia salina (Molina) I. M. Johnston. Furthermore, the ovipositional response to F. salina was substantially lower than that recorded in laboratory tests. The percent of eggs laid on F. salina in field tests was 3.7 in a paired choice cage test, 4.3 in a multiple choice cage test, and 2.5 in a multiple choice open field test, suggesting that the true acceptance rate of the nontarget by D. elongata in the field will be lower than laboratory tests predicted. However, some damage was caused to F. salina by adult and larval feeding in the field, although this occurred only at the very end of the open field test, when D. elongata densities were extremely high, and all of the surrounding saltcedar had been totally defoliated. Scientific representatives from various stakeholder organizations (state, county, university, and environmental groups) viewed the open field test when in progress and reviewed the final results before advising State regulatory agencies on beetle redistribution. These test results, and the open review process, led regulators to conclude that redistribution of D. elongata in California was warranted owing to its significant ability to defoliate saltcedar, and its low rate of feeding on nontarget Frankenia spp. The introduction of D. elongata provides an interesting case study for risk assessment of a potentially efficacious weed biocontrol agent that may also be capable of using nontarget native plants.


Subject(s)
Biological Control Agents , Coleoptera/physiology , Food Chain , Herbivory , Magnoliopsida/growth & development , Animals , California , Coleoptera/growth & development , Greece , Larva/physiology , Oviposition , Species Specificity , Tamaricaceae/growth & development
9.
Dev Dyn ; 242(12): 1405-26, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24038607

ABSTRACT

BACKGROUND: Sperm Acrosomal SLLP1 Binding (SAS1B) protein (ovastacin) is an oolemmal binding partner for the intra-acrosomal sperm protein SLLP1. RESULTS: Immunohistochemical localization revealed that SAS1B translation is restricted among adult tissues to the ovary and oocytes, SAS1B appearing first in follicles at the primary-secondary transition. Quiescent oocytes within primordial follicles and primary follicles did not stain for SAS1B. Examination of neonatal rat ovaries revealed SAS1B expression first as faint signals in postnatal day 3 oocytes, with SAS1B protein staining intensifying with oocyte growth. Irrespective of animal age or estrus stage, SAS1B was seen only in oocytes of follicles that initiated a second granulosa cell layer. The precise temporal and spatial onset of SAS1B expression was conserved in adult ovaries in seven eutherian species, including nonhuman primates. Immunoelectron micrographs localized SAS1B within cortical granules in MII oocytes. A population of SAS1B localized on the oolemma predominantly in the microvillar region anti-podal to the nucleus in ovulated MII rat oocytes and on the oolemma in macaque GV oocytes. CONCLUSIONS: The restricted expression of SAS1B protein in growing oocytes, absence in the ovarian reserve, and localization on the oolemma suggest this zinc metalloprotease deserves consideration as a candidate target for reversible female contraceptive strategies.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Mammals/metabolism , Metalloproteases/metabolism , Oocytes/metabolism , Ovarian Follicle/physiology , Animals , Base Sequence , Blotting, Western , Cloning, Molecular , Cricetinae , DNA Primers/genetics , Evolution, Molecular , Female , Gene Expression Profiling , Humans , Immunohistochemistry , Mammals/growth & development , Mice , Molecular Sequence Data , Oocytes/growth & development , Ovarian Follicle/metabolism , Rabbits , Rats , Sequence Analysis, DNA , Species Specificity
10.
Structure ; 20(10): 1715-25, 2012 Oct 10.
Article in English | MEDLINE | ID: mdl-22940582

ABSTRACT

Proteins of unknown function comprise a significant fraction of sequenced genomes. Defining the roles of these proteins is vital to understanding cellular processes. Here, we describe a method to determine a protein function based on the identification of its natural ligand(s) by the crystallographic screening of the binding of a metabolite library, followed by a focused search in the metabolic space. The method was applied to two protein families with unknown function, PF01256 and YjeF_N. The PF01256 proteins, represented by YxkO from Bacillus subtilis and the C-terminal domain of Tm0922 from Thermotoga maritima, were shown to catalyze ADP/ATP-dependent NAD(P)H-hydrate dehydratation, a previously described orphan activity. The YjeF_N proteins, represented by mouse apolipoprotein A-I binding protein and the N-terminal domain of Tm0922, were found to interact with an adenosine diphosphoribose-related substrate and likely serve as ADP-ribosyltransferases. Crystallographic screening of metabolites serves as an efficient tool in functional analyses of uncharacterized proteins.


Subject(s)
ADP Ribose Transferases/chemistry , Bacterial Proteins/chemistry , Carrier Proteins/chemistry , Hydro-Lyases/chemistry , Phosphoproteins/chemistry , Animals , Bacillus subtilis/enzymology , Catalytic Domain , Crystallography, X-Ray , Hydrogen Bonding , Mice , Models, Molecular , Molecular Sequence Annotation , Protein Binding , Protein Structure, Secondary , Protein Structure, Tertiary , Racemases and Epimerases , Small Molecule Libraries/chemistry , Thermotoga maritima/enzymology
11.
J Urol ; 187(5): 1918-23, 2012 May.
Article in English | MEDLINE | ID: mdl-22425054

ABSTRACT

PURPOSE: Microdissection testicular sperm extraction markedly improves the sperm retrieval rates in men with nonobstructive azoospermia. However, localizing sperm foci can be time-consuming and it is not always successful. Fiberoptic confocal fluorescent microscopy offers the advantage of rapid in vivo detection of fluorescently labeled sperm in the seminiferous tubules. MATERIALS AND METHODS: After establishing the feasibility of fiberoptic confocal fluorescent microscopy to identify antibody labeled sperm in vivo C57/B6 mice underwent intraperitoneal injection of busulfan to induce azoospermia. During spermatogenesis reestablishment at approximately 16 weeks the mice were anesthetized and the testes were delivered through a low midline incision. Fluorescein isothiocyanate labeled antibody to intra-acrosomal protein Hs-14 was injected retrograde into a single murine rete testis. The testes were imaged in vivo with fiberoptic confocal fluorescent microscopy and sperm foci were detected. The respective seminiferous tubules were excised and squash prepared for immunofluorescence microscopy. RESULTS: Sperm foci were identified in the testis injected with fluorescently tagged antibody by in vivo fiberoptic confocal fluorescence microscopy. The contralateral control testis of each mouse showed no specific signal. Immunofluorescence microscopy of the excised tubules provided morphological confirmation of the presence of labeled sperm with an absence in controls. Findings were consistent in the feasibility portion of the study and in the busulfan model of nonobstructive azoospermia. CONCLUSIONS: Fiberoptic confocal fluorescent microscopy was feasible during microdissection testicular sperm extraction in an azoospermic mouse model to identify fluorescently labeled sperm in vivo. Translation to the clinical setting could decrease operative time and improve the sperm harvest rate.


Subject(s)
Microdissection/methods , Sperm Retrieval , Testis/cytology , Animals , Azoospermia/chemically induced , Busulfan/adverse effects , Disease Models, Animal , Male , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Microscopy, Fluorescence , Seminiferous Tubules/metabolism , Tissue and Organ Harvesting/methods
12.
Dev Biol ; 363(1): 40-51, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22206759

ABSTRACT

Molecular mechanisms by which fertilization competent acrosome-reacted sperm bind to the oolemma remain uncharacterized. To identify oolemmal binding partner(s) for sperm acrosomal ligands, affinity panning was performed with mouse oocyte lysates using sperm acrosomal protein, SLLP1 as a target. An oocyte specific membrane metalloproteinase, SAS1B (Sperm Acrosomal SLLP1 Binding), was identified as a SLLP1 binding partner. cDNA cloning revealed six SAS1B splice variants, each containing a zinc binding active site and a putative transmembrane domain, with signal peptides in three variants. SAS1B transcripts were ovary specific. SAS1B protein was first detected in early secondary follicles in day 3 ovaries. Immunofluorescence localized SAS1B to the microvillar oolemma of M2 oocytes. After fertilization, SAS1B decreased on the oolemma and became virtually undetectable in blastocysts. In transfected CHO-K1 cells SAS1B localized to the surface of unpermeabilized cells. Recombinant and native SLLP1 co-localized with SAS1B to the microvillar domain of ovulated M2 oocytes. Molecular interactions between mouse SLLP1 and SAS1B were demonstrated by surface plasmon resonance, far-western, yeast two-hybrid, recombinant- and native-co-IP analyses. SAS1B bound to SLLP1 with high affinity. SAS1B had protease activity, and SAS1B protein or antibody significantly inhibited fertilization. SAS1B knockout female mice showed a 34% reduction in fertility. The study identified SAS1B-SLLP1 as a pair of novel sperm-egg binding partners involving the oolemma and intra-acrosomal compartment during fertilization.


Subject(s)
Fertilization , Isoantigens/metabolism , Metalloproteases/metabolism , Oocytes/metabolism , Seminal Plasma Proteins/metabolism , Acrosome/metabolism , Alternative Splicing , Animals , Binding, Competitive , Blotting, Far-Western , CHO Cells , Cell Membrane/metabolism , Cricetinae , Cricetulus , Female , Immunoprecipitation , Isoantigens/genetics , Male , Metalloproteases/genetics , Mice , Mice, Inbred ICR , Mice, Knockout , Pregnancy , Protein Binding , Protein Isoforms/genetics , Protein Isoforms/metabolism , Seminal Plasma Proteins/genetics , Sperm-Ovum Interactions , Surface Plasmon Resonance , Two-Hybrid System Techniques
13.
J Reprod Immunol ; 89(1): 95-102, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21470689

ABSTRACT

We have employed a proteomic approach to study the immune response to human sperm in an infertile female patient suffering from systemic lupus erythematosus (SLE). Human sperm antigenic extracts were resolved by means of two-dimensional electrophoresis and electroblotted onto nitrocellulose membranes. The membranes were incubated with serum from the SLE patient. Sperm antigens that were reactive to polyclonal antibodies were next visualized on X-ray film, using the enhanced chemiluminescence (ECL). Three spots corresponding to the positions of sperm immunoreactive antigens on a nitrocellulose membrane were localized in a silver stained gel and subjected to mass spectrometry. A database search of the sequences recognized by the analyzed SLE serum revealed its homology to the clathrin heavy chain (CHC). Further analysis revealed that anti-CHC antibody reacted with multiple sperm antigenic determinants, resolved by either one- or two-dimensional electrophoresis. When studied by immunofluorescence, we demonstrated anti-CHC antibody reactivity with the sperm tail tip (corresponding to the sperm agglutination pattern), also with the principal piece and with cytoplasmic droplets around the sperm midpiece. Live sperm clearly exhibited reactivity with the midpiece. This study demonstrates clathrin heavy chain on human sperm using serum of an infertile individual with a concomitant autoimmune disease.


Subject(s)
Clathrin/metabolism , Infertility, Female/immunology , Lupus Erythematosus, Systemic/immunology , Adult , Clathrin/immunology , Cross Reactions , Epitopes/metabolism , Female , Humans , Infertility, Female/blood , Infertility, Female/complications , Isoantibodies/blood , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/complications , Male , Mass Spectrometry , Protein Binding , Proteomics , Sperm Agglutination/immunology , Sperm Tail/metabolism
14.
Asian J Androl ; 13(2): 266-74, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21240291

ABSTRACT

Calcium-binding tyrosine phosphorylation-regulated protein (CABYR) is a highly polymorphic calcium-binding tyrosine- and serine-/threonine-phosphorylated fibrous sheath (FS) protein involved in capacitation. A putative domain (amino acids 12-48) homologous to the regulatory subunit of type II cAMP-dependent protein kinase A (RII) dimerisation and A kinase-anchoring protein (AKAP)-binding domains of protein kinase A at the N-terminus suggests that CABYR may self-assemble and bind to AKAPs. Moreover, there is evidence that CABYR has limited interaction with AKAPs. However, further evidence and new relationships between CABYR and other FS proteins, including AKAPs, will be helpful in understanding the basic physiology of FS. In this study, a new strategy for co-immunoprecipitation of insoluble proteins, as well as the standard co-immunoprecipitation method in combination with mass spectrometry and western blot, was employed to explore the relationship between CABYR, AKAP3 and Ropporin. The results showed that AKAP3 was co-immunoprecipitated with CABYR by the anti-CABYR-A polyclonal antibody, and, conversely, CABYR was also co-immunoprecipitated with AKAP3 by the anti-AKAP3 polyclonal antibody. Another RII-like domain containing protein, Ropporin, was also co-immunoprecipitated with CABYR, indicating that Ropporin is one of CABYR's binding partners. The interactions between CABYR, AKAP3 and Ropporin were confirmed by yeast two-hybrid assays. Further analysis showed that CABYR not only binds to AKAP3 by its RII domain but binds to Ropporin through other regions besides the RII-like domain. This is the first demonstration that CABYR variants form a complex not only with the scaffolding protein AKAP3 but also with another RII-like domain-containing protein in the human sperm FS.


Subject(s)
A Kinase Anchor Proteins/metabolism , Calcium-Binding Proteins/metabolism , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Sperm Tail/metabolism , rho GTP-Binding Proteins/metabolism , A Kinase Anchor Proteins/chemistry , A Kinase Anchor Proteins/genetics , Amino Acid Sequence , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/genetics , Genetic Variation , Humans , Immunoprecipitation , Male , Membrane Proteins/chemistry , Membrane Proteins/genetics , Molecular Sequence Data , Multiprotein Complexes/chemistry , Phosphoproteins/chemistry , Phosphoproteins/genetics , Protein Binding , Protein Interaction Domains and Motifs , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sperm Tail/ultrastructure , Two-Hybrid System Techniques , rho GTP-Binding Proteins/chemistry , rho GTP-Binding Proteins/genetics
15.
Reprod Biol Endocrinol ; 8: 101, 2010 Aug 23.
Article in English | MEDLINE | ID: mdl-20731842

ABSTRACT

BACKGROUND: CABYR is a polymorphic calcium-binding protein of the sperm fibrous sheath (FS) which gene contains two coding regions (CR-A and CR-B) and is tyrosine as well as serine/threonine phosphorylated during in vitro sperm capacitation. Thus far, the detailed information on CABYR protein expression in mouse spermatogenesis is lacking. Moreover, because of the complexity of this polymorphic protein, there are no data on how CABYR isoforms associate and assemble into the FS. METHODS: The capacity of mouse CABYR isoforms to associate into dimers and oligomers, and the relationships between CABYR and other FS proteins were studied by gel electrophoresis, Western blotting, immunofluorescence, immunoprecipitation and yeast two-hybrid analyses. RESULTS: The predominant form of mouse CABYR in the FS is an 80 kDa variant that contains only CABYR-A encoded by coding region A. CABYR isoforms form dimers by combining the 80 kDa CABYR-A-only variant with the 50 kDa variant that contains both CABYR-A and CABYR-B encoded by full length or truncated coding region A and B. It is proposed that this step is followed by the formation of larger oligomers, which then participate in the formation of the supramolecular structure of the FS in mouse sperm. The initial expression of CABYR occurs in the cytoplasm of spermatids at step 11 of spermiogenesis and increases progressively during steps 12-15. CABYR protein gradually migrates into the sperm flagellum and localizes to the FS of the principal piece during steps 15-16. Deletion of the CABYR RII domain abolished the interaction between CABYR and AKAP3/AKAP4 but did not abolish the interaction between CABYR and ropporin suggesting that CABYR binds to AKAP3/AKAP4 by its RII domain but binds to ropporin through another as yet undefined region. CONCLUSIONS: CABYR expresses at the late stage of spermiogenesis and its isoforms oligomerize and bind with AKAPs and ropporin. These interactions strongly suggest that CABYR participates in the assembly of complexes in the FS, which may be related to calcium signaling.


Subject(s)
A Kinase Anchor Proteins/metabolism , Calcium-Binding Proteins/metabolism , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Spermatogenesis , Spermatozoa/metabolism , rho GTP-Binding Proteins/metabolism , A Kinase Anchor Proteins/genetics , Animals , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/genetics , Male , Membrane Proteins/genetics , Mice , Mice, Inbred ICR , Phosphoproteins/chemistry , Phosphoproteins/genetics , Protein Binding , Protein Interaction Domains and Motifs/physiology , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Multimerization/physiology , Sperm Capacitation/physiology , Sperm Tail/metabolism , Sperm Tail/ultrastructure , Spermatogenesis/genetics , Spermatogenesis/physiology , Spermatozoa/physiology , Spermatozoa/ultrastructure , Time Factors , rho GTP-Binding Proteins/genetics
16.
Reprod Biol Endocrinol ; 8: 6, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-20078857

ABSTRACT

BACKGROUND: The precise composition of the human sperm plasma membrane, the molecular interactions that define domain specific functions, and the regulation of membrane associated proteins during the capacitation process, still remain to be fully understood. Here, we investigated the repertoire of calcium-regulated proteins associated with the human sperm plasma membrane. METHODS: Surface specific radioiodination was combined with two-dimensional gel electrophoresis, a 45Ca-overlay assay, computer assisted image analysis and mass spectrometry to identify calcium-binding proteins exposed on the human sperm surface. RESULTS: Nine acidic 45Ca-binding sperm proteins were excised from stained preparative 2D gels and identified by mass spectrometry. Five of the calcium binding proteins; HSPA2 (HSP70-1), HSPA5 (Bip), HYOU1 (ORP150), serum amyloid P-component (SAP) and protein kinase C substrate 80K-H (80K-H) were found to be accessible to Iodo-Bead catalyzed 125I-labelling on the surface of intact human sperm. Agglutination and immunofluorescence analysis confirmed that SAP is situated on the plasma membrane of intact, motile sperm as well as permeabilized cells. Western blot analysis showed increased phosphorylation of human sperm 80K-H protein following in vitro capacitation. This is the first demonstration of the 80K-H protein in a mammalian sperm. CONCLUSION: The presence of SAP on the surface of mature sperm implies that SAP has a physiological role in reproduction, which is thought to be in the removal of spermatozoa from the female genital tract via phagocytosis. Since 80K-H is a Ca2+-sensor recently implicated in the regulation of both inositol 1,4,5-trisphosphate receptor and transient receptor potential (TRP) cation channel activities, its detection in sperm represents the first direct signaling link between PKC and store-operated calcium channels identified in human sperm.


Subject(s)
Calcium-Binding Proteins/isolation & purification , Cell Membrane/metabolism , Spermatozoa/metabolism , Calcium/metabolism , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Electrophoresis, Gel, Two-Dimensional , Endoplasmic Reticulum Chaperone BiP , Humans , Male , Semen Analysis/methods , Sperm Agglutination/physiology , Sperm Capacitation/physiology , Young Adult
17.
J Reprod Immunol ; 84(1): 32-40, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19962198

ABSTRACT

The sperm plasma membrane is known to be critical to fertilization and to be highly regionalized into domains of head, mid- and principal pieces. However, the molecular composition of the sperm plasma membrane and its alterations during genital tract passage, capacitation and the acrosome reaction remains to be fully dissected. A two-dimensional gel-based proteomic study previously identified 98 human sperm proteins which were accessible for surface labelling with both biotin and radioiodine. In this report twelve dually labelled protein spots were excised from stained gels or PDVF membranes and analysed by mass spectrometry (MS) and Edman degradation. Seven members from four different heat shock protein (HSP) families were identified including HYOU1 (ORP150), HSPC1 (HSP86), HSPA5 (Bip), HSPD1 (HSP60), and several isoforms of the two testis-specific HSP70 chaperones HSPA2 and HSPA1L. An antiserum raised against the testis-specific HSPA2 chaperone reacted with three 65kDa HSPA2 isoforms and three high molecular weight surface proteins (78-79kDa, 84kDa and 90-93kDa). These proteins, together with seven 65kDa HSP70 forms, reacted with human anti-sperm IgG antibodies that blocked in vitro fertilization in humans. Three of these surface biotinylated human sperm antigens were immunoprecipitated with a rabbit antiserum raised against a linear peptide epitope in Chlamydia trachomatis HSP70. The results indicate diverse HSP chaperones are accessible for surface labelling on human sperm. Some of these share epitopes with C. trachomatis HSP70, suggesting an association between genital tract infection, immunity to HSP70 and reproductive failure.


Subject(s)
Cell Membrane/metabolism , Heat-Shock Proteins/metabolism , Spermatozoa/metabolism , Acrosome Reaction/immunology , Animals , Antigens/immunology , Chlamydia Infections/immunology , Endoplasmic Reticulum Chaperone BiP , Epitopes/immunology , Female , Heat-Shock Proteins/chemistry , Humans , Male , Molecular Chaperones/chemistry , Molecular Chaperones/metabolism , Rabbits , Spermatozoa/chemistry
18.
Proc Natl Acad Sci U S A ; 106(40): 17055-60, 2009 Oct 06.
Article in English | MEDLINE | ID: mdl-19805151

ABSTRACT

Spermatogenesis can be divided into three stages: spermatogonial mitosis, meiosis of spermatocytes, and spermiogenesis. During spermiogenesis, spermatids undergo dramatic morphological changes including formation of a flagellum and chromosomal packaging and condensation of the nucleus into the sperm head. The genes regulating the latter processes are largely unknown. We previously discovered that a bi-functional gene, Spag16, is essential for spermatogenesis. SPAG16S, the 35 kDa, testis-specific isoform derived from the Spag16 gene, was found to bind to meiosis expressed gene 1 product (MEIG1), a protein originally thought to play a role in meiosis. We inactivated the Meig1 gene and, unexpectedly, found that Meig1 mutant male mice had no obvious defect in meiosis, but were sterile as a result of impaired spermatogenesis at the stage of elongation and condensation. Transmission electron microscopy revealed that the manchette, a microtubular organelle essential for sperm head and flagellar formation was disrupted in spermatids of MEIG1-deficient mice. We also found that MEIG1 associates with the Parkin co-regulated gene (PACRG) protein, and that testicular PACRG protein is reduced in MEIG1-deficient mice. PACRG is thought to play a key role in assembly of the axonemes/flagella and the reproductive phenotype of Pacrg-deficient mice mirrors that of the Meig1 mutant mice. Our findings reveal a critical role for the MEIG1/PARCG partnership in manchette structure and function and the control of spermiogenesis.


Subject(s)
Cell Cycle Proteins/physiology , Nuclear Proteins/physiology , Phosphoproteins/physiology , Spermatids/physiology , Spermatogenesis/physiology , Amino Acid Sequence , Animals , Blotting, Western , COS Cells , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Chlorocebus aethiops , DNA-Binding Proteins , Genes, Essential , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunoprecipitation , Male , Mice , Mice, Knockout , Microfilament Proteins , Microscopy, Electron , Molecular Chaperones , Molecular Sequence Data , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , Protein Transport , Proteins/genetics , Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Spermatids/metabolism , Spermatids/ultrastructure , Spermatogenesis/genetics , Testis/cytology , Testis/metabolism , Testis/ultrastructure , Two-Hybrid System Techniques
19.
J Urol ; 180(6): 2569-76, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18930494

ABSTRACT

PURPOSE: Compliance with post-vasectomy semen analysis could be improved with the availability of a simple, rapid and accurate home test. SpermCheck Vasectomy, a highly sensitive lateral flow immunochromatographic diagnostic device, was designed to detect extreme oligospermia or azoospermia in men after vasectomy. We report the results of clinical and consumer testing of SpermCheck. MATERIALS AND METHODS: A prospective, noncomparative observational study assessed the ability of SpermCheck Vasectomy to predict post-vasectomy sperm counts obtained using a hemacytometer procedure based on standard World Health Organization methodology. Consumer studies evaluated ease of use. RESULTS: A cohort of 144 post-vasectomy semen samples was tested in the clinical trial. SpermCheck was 96% accurate in predicting whether sperm counts were greater or less than a threshold of 250,000 sperm per ml, a level associated with little or no risk of pregnancy. Sensitivity was 93% (95% CI 79% to 98%) and specificity was 97% (91% to 99%). The positive predictive value of the test was 93% (79% to 98%), and most importantly the negative predictive value was 97% (91% to 99%). The test gave a positive result 100% of the time at sperm concentrations of 385,000/ml or greater. Consumer studies with 109 lay volunteers showed that SpermCheck was easy to use. Volunteers obtained the correct or expected test result in every case and the correct response rate on a 20 question survey about the test was 97%. CONCLUSIONS: SpermCheck Vasectomy, a simple and reliable immunodiagnostic test that can provide evidence of vasectomy success or failure, offers a useful alternative to improve compliance with post-vasectomy sperm monitoring. It is currently the only Food and Drug Administration approved test for this purpose.


Subject(s)
Consumer Behavior , Immunologic Tests/instrumentation , Reagent Kits, Diagnostic , Sperm Count/instrumentation , Vasectomy , Adolescent , Adult , Aged , Equipment Design , Humans , Male , Middle Aged , Prospective Studies , Sensitivity and Specificity , Young Adult
20.
Dev Biol ; 319(2): 211-22, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18533145

ABSTRACT

Targeted deletion of Tssk1 and 2 resulted in male chimeras which produced sperm/spermatogenic cells bearing the mutant allele, however this allele was never transmitted to offspring, indicating infertility due to haploinsufficiency. Morphological defects in chimeras included failure to form elongated spermatids, apoptosis of spermatocytes and spermatids, and the appearance of numerous round cells in the epididymal lumen. Characterization of TSSK2 and its interactions with the substrate, TSKS, were further investigated in human and mouse. The presence of both kinase and substrate in the testis was confirmed, while persistence of both proteins in spermatozoa was revealed for the first time. In vivo binding interactions between TSSK2 and TSKS were established through co-immunoprecipitation of TSSK2/TSKS complexes from both human sperm and mouse testis extracts. A role for the human TSKS N-terminus in enzyme binding was defined by deletion mapping. TSKS immunoprecipitated from both mouse testis and human sperm extracts was actively phosphorylated. Ser281 was identified as a phosphorylation site in mouse TSKS. These results confirm both TSSK 2 and TSKS persist in sperm, define the critical role of TSKS' N-terminus in enzyme interaction, identify Ser 281 as a TSKS phosphorylation site and indicate an indispensable role for TSSK 1 and 2 in spermiogenesis.


Subject(s)
Infertility, Male/enzymology , Infertility, Male/genetics , Loss of Heterozygosity , Protein Serine-Threonine Kinases/deficiency , Animals , Genomics , Humans , Male , Mice , Mice, Knockout , Mice, Mutant Strains , Protein Serine-Threonine Kinases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...